Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Whether tirzepatide is appropriate depends on a persons medical history, treatment goals, potential risks, and response to care
Key therapies such as antacids, proton pump inhibitors (PPIs), H2 receptor antagonists, and prokinetics continue to dominate, with both OTC and prescription drugs making management more accessible
it also influences central immune command centers, particularly the hypothalamus
Adverse Reactions/Side Effects The following clinically significant adverse reactions are described elsewhere in the labeling: Embryo-Fetal Toxicity [see Warnings and Precautions (5.1) and Use in Specific Populations (8.1, 8.6)] Suicidal Behavior and Ideation [see Warnings and Precautions (5.2)] Risk of Ophthalmologic Adverse Reactions [see Warnings and Precautions (5.3)] Mood and Sleep Disorders [see Warnings and Precautions (5.4)] Cognitive Impairment [see Warnings and Precautions (5.5)] Slowing of Linear Growth [see Warnings and Precautions (5.6)] Metabolic Acidosis [see Warnings and Precautions (5.7)] Decrease in Renal Function [see Warnings and Precautions (5.8)] Risk of Seizures with Abrupt Withdrawal of QSYMIA [see Warnings and Precautions (5.9)] Kidney Stones [see Warnings and Precautions (5.10)] Oligohydrosis and Hyperthermia [see Warnings and Precautions (5.11)] Hypokalemia [see Warnings and Precautions (5.12)] Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity Reactions [ see Warnings and Precautions (5.13)] Serious Skin Reactions [see Warnings and Precautions (5.14)] Anaphylaxis and Angioedema [see Warnings and Precautions (5.15)] Allergic Reactions Due to Inactive Ingredient FD&C Yellow No
US$ 21.67
US$ 20.43
US$ 22.83
